SCHEMBL20142858

SCHEMBL20142858

Nc1nc(Nc2ccc(OC(F)(F)F)cc2)sc1C(=O)c1cccnc1

nearest known ligand 0.72

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CCNA2 P20248 8/20 0.72
CDK2 P24941 8/20 0.72
CDK5 Q00535 10/20 0.70
CDK5R1 Q15078 10/20 0.70
CCNE1 P24864 1/20 0.67
NPC1 O15118 3/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
MAPT P10636 1/20 0.56
GSK3A P49840 1/20 0.56
GSK3B P49841 1/20 0.56
RAB9A P51151 1/20 0.56
MAPK14 Q16539 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
CHRNA7 P36544 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25609586 0.89 CCNA2 (0.72) CCNA2CDK2CDK5CDK5R1NPC1
SCHEMBL4395888 0.88 CDK5 (0.80) CCNA2CDK2CDK5CDK5R1CCNE1
SCHEMBL20142140 0.88 CDK5 (0.69) CCNA2CDK2CDK5CDK5R1NPC1
SCHEMBL20142395 0.87 CCNA2 (0.77) CCNA2CDK2CDK5CDK5R1CCNE1
SCHEMBL20142498 0.85 CCNA2 (0.52) CCNA2CDK2CDK5CDK5R1CCNE1
SCHEMBL7756155 0.84 CDK5 (0.76) CCNA2CDK2CDK5CDK5R1NPC1
SCHEMBL1248181 0.84 CDK2 (1.00) CCNA2CDK2CDK5CDK5R1CCNE1
SCHEMBL25220987 0.83 MEN1 (0.78) CCNA2CDK2CDK5CDK5R1NPC1
SCHEMBL20142855 0.83 MEN1 (0.68) CCNA2CDK2CDK5CDK5R1NPC1
SCHEMBL25609594 0.83 MEN1 (0.78) CCNA2CDK2CDK5CDK5R1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089902-A1 DIAMINOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE APOGEE BIOTECHNOLOGY CORPORATION (US) 2018-05-17 WO claimed
WO-2018089902-A1 DIAMINOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE APOGEE BIOTECHNOLOGY CORPORATION (US) 2018-05-17 WO disclosed